Trexquant Investment’s Vanda Pharmaceuticals VNDA Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-192,110
Closed -$882K 1911
2025
Q1
$882K Sell
192,110
-34,566
-15% -$159K 0.01% 1127
2024
Q4
$1.09M Buy
226,676
+22,229
+11% +$106K 0.01% 1080
2024
Q3
$959K Buy
204,447
+132,613
+185% +$622K 0.01% 1064
2024
Q2
$406K Buy
+71,834
New +$406K 0.01% 1300
2024
Q1
Sell
-104,511
Closed -$441K 1817
2023
Q4
$441K Sell
104,511
-169,741
-62% -$716K 0.01% 1122
2023
Q3
$1.18M Buy
274,252
+262,088
+2,155% +$1.13M 0.03% 684
2023
Q2
$80.2K Sell
12,164
-37,293
-75% -$246K ﹤0.01% 1378
2023
Q1
$336K Sell
49,457
-12,285
-20% -$83.4K 0.01% 1155
2022
Q4
$456K Buy
61,742
+29,820
+93% +$220K 0.01% 952
2022
Q3
$315K Buy
31,922
+2,948
+10% +$29.1K 0.01% 1009
2022
Q2
$316K Sell
28,974
-41,203
-59% -$449K 0.01% 1089
2022
Q1
$794K Buy
70,177
+41,254
+143% +$467K 0.04% 569
2021
Q4
$454K Buy
+28,923
New +$454K 0.03% 698
2021
Q2
Sell
-15,393
Closed -$231K 1532
2021
Q1
$231K Buy
15,393
+575
+4% +$8.63K 0.02% 902
2020
Q4
$195K Sell
14,818
-38,911
-72% -$512K 0.02% 891
2020
Q3
$519K Buy
53,729
+3,267
+6% +$31.6K 0.03% 664
2020
Q2
$577K Buy
+50,462
New +$577K 0.04% 618
2019
Q4
Sell
-29,800
Closed -$396K 1287
2019
Q3
$396K Buy
29,800
+8,608
+41% +$114K 0.03% 528
2019
Q2
$299K Buy
+21,192
New +$299K 0.03% 603
2018
Q4
Sell
-22,837
Closed -$524K 1326
2018
Q3
$524K Buy
22,837
+11,683
+105% +$268K 0.04% 521
2018
Q2
$212K Buy
+11,154
New +$212K 0.01% 776
2017
Q3
Sell
-23,568
Closed -$384K 1048
2017
Q2
$384K Buy
+23,568
New +$384K 0.11% 347
2016
Q4
Sell
-11,100
Closed -$185K 1147
2016
Q3
$185K Buy
+11,100
New +$185K 0.04% 651
2016
Q1
Sell
-57,005
Closed -$531K 1199
2015
Q4
$531K Buy
+57,005
New +$531K 0.05% 658
2015
Q2
Sell
-78,400
Closed -$729K 1257
2015
Q1
$729K Buy
+78,400
New +$729K 0.07% 520